{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:07:18Z","timestamp":1784610438644,"version":"3.55.0"},"reference-count":58,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/21645515.2026.2702726","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:49:57Z","timestamp":1784609397000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The relative immunogenicity of 20-valent and 15-valent pneumococcal conjugate vaccines: A systematic review and network meta-analysis"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-7495","authenticated-orcid":false,"given":"Ilaria","family":"Valentini","sequence":"first","affiliation":[{"name":"Universit\u00e0 Cattolica del Sacro Cuore","place":["Rome, Italy"]},{"name":"University of Perugia","place":["Perugia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Alessandra","family":"Strangi","sequence":"additional","affiliation":[{"name":"Hygiene and Public Health Service, ASL Roma 1","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Baccarini","sequence":"additional","affiliation":[{"name":"University of Perugia","place":["Perugia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Martini","sequence":"additional","affiliation":[{"name":"Hospital of Perugia","place":["Perugia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Paoloni","sequence":"additional","affiliation":[{"name":"University of Perugia","place":["Perugia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Mannocci","sequence":"additional","affiliation":[{"name":"San Raffaele University of Rome","place":["Rome, Italy"]},{"name":"IRCCS San Raffaele Rome","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"de Waure","sequence":"additional","affiliation":[{"name":"University of Perugia","place":["Perugia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.093"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03937.x"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12461"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30310-4"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01733-z"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00665-0"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13161982"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30247-X"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000348"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11061376"},{"key":"e_1_3_5_12_1","unstructured":"World Health Organization. Pneumococcal disease [Internet]. [accessed 2024 Nov 21]. https:\/\/www.who.int\/teams\/health-product-policy-and-standards\/standards-and-specifications\/norms-and-standards\/vaccine-standardization\/pneumococcal-disease."},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.01.021"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.05.102"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001517"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-207"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1688149"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2801.210734"},{"key":"e_1_3_5_19_1","unstructured":"European Medicines Agency. Apexxnar [Pneumococcal polysaccharide conjugate vaccine (20-valent adsorbed)]: summary of product characteristics. [Internet]. 2022. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/prevenar-20."},{"key":"e_1_3_5_20_1","unstructured":"US FDA. PREVNAR 20 (pneumococcal 20-valent conjugate vaccine) suspension for intramuscular injection: US prescribing information [Internet]. 2021. https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/prevnar-20."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11071816"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12050732"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102073"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7401a1"},{"key":"e_1_3_5_25_1","unstructured":"Valentini I Strangi EA Baccarini G Martini C Paoloni M Mannocci A de Waure C. Protocollo: the relative immunogenicity of the new 20-valent and 15-valent pneumococcal conjugate vaccine: a systematic review and network meta-analysis. [Internet]. 2025 [accessed 2026 Jan 29]. https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251177861."},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"e_1_3_5_27_1","volume-title":"Version 6.5, 2024","author":"Higgins J","year":"2024","unstructured":"Higgins J, Savovi\u0107 J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: assessing risk of bias in a randomized trial [Internet]. Version 6.5, 2024. 2024 [accessed 2024 Nov 21]. https:\/\/training.cochrane.org\/handbook\/current\/chapter-08."},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4501"},{"key":"e_1_3_5_29_1","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024)","author":"Higgins J","year":"2024","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024). Cochrane; 2024. www.cochrane.org\/handbook."},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1045"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab990"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab605"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2177066"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.09.043"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.07.004"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1532250"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2126253"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1532249"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.10.032"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.03.012"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.08.049"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.12.067"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.08.038"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.JJID.2022.060"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.01.004"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1863177"},{"key":"e_1_3_5_47_1","unstructured":"ECDC. Invasive pneumococcal disease - annual epidemiological report for 2022 [Internet]. 2025 [accessed 2026 Jan 4]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/invasive-pneumococcal-disease-annual-epidemiological-report-2022."},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf069"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2025.2569037"},{"key":"e_1_3_5_50_1","doi-asserted-by":"crossref","unstructured":"Kobayashi M. Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged \u226550 years: recommendations of the advisory committee on immunization practices\u2014United States 2024 [Internet]. 2025 [accessed 2025 Oct 3]. https:\/\/www.cdc.gov\/mmwr\/volumes\/74\/wr\/mm7401a1.htm.","DOI":"10.15585\/mmwr.mm7401a1"},{"key":"e_1_3_5_51_1","unstructured":"NIAC. NIAC updated recommendations for pneumococcal conjugate vaccination in childhood. Royal College of Physicians of Ireland. 2024 [accessed 2025 Oct 3]. https:\/\/www.nitag-resource.org\/sites\/default\/files\/2024-11\/NIAC%20updated%20recommendations%20for%20pneumococcal%20conjugate%20vaccination%20in%20childhood%20_%20Royal%20College%20of%20Physicians%20of%20Ireland.pdf."},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126656"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12232490"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2025.2495461"},{"key":"e_1_3_5_55_1","unstructured":"Canada. Economic evidence supplementary appendix: recommendations for public health programs on the use of pneumococcal vaccines in children. 2024 [accessed 2025 Oct 3]. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/national-advisory-committee-immunization-recommendations-public-health-programs-use-pneumococcal-vaccines-children-including-use-15-valent-20-valent-conjugate-vaccines-economic-evidence-supplementary-appendix.html."},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2025.100682"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00400-6"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v50i12a04"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.52225\/narrax.v3i3.230"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2702726","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2026.2702726","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2702726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:50:08Z","timestamp":1784609408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2026.2702726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/21645515.2026.2702726"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2026.2702726","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2702726"}}